“…Good NGF mimetics at this stage appear to be D3 or its derivatives and LM11A-24 or LM11A-31, although each may potentially be useful for a distinct purpose. Also being developed are TrkB (O' Leary & Hughes, 2003;Fletcher, et al, 2008;Fletcher & Hughes, 2009) and TrkC Chen, et al, 2009;Liu, et al, 2010) antagonists/agonists. BDNF mimetics have made progress toward a useful therapeutic reagent with efficacy studies in rodents (Massa et al, 2010).…”